Expression of Interferon Regulatory Factor 4 in Chronic Myeloid Leukemia: Correlation With Response to Interferon Alfa Therapy
Manuel Schmidt(Mologen (Germany)), Andreas Neubauer(RWTH Aachen University), Gerhard Ehninger(University Hospital Carl Gustav Carus), Sven A. König-Merediz(Heidelberg University), Jutta Proba(Heidelberg University), Andreas Hochhaus(Jena University Hospital), Cornelia Brendel(Philipps University of Marburg), Georg J. Hoppe(Heidelberg University), Burghardt Wittig, Rüdiger Hehlmann(Heidelberg University)
Cited by 51
Related Papers
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
|Leukemia|2022|3.8k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Diverse Applications of Nanomedicine
|ACS Nano|2017|1.4k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k